The Ultragenyx earnings call is scheduled for November 3, 2026, at 5 p.m. Eastern Time, when the company plans to discuss its third-quarter financial results and provide a corporate update.

Ultragenyx earnings call to cover third quarter

The call will cover the quarter ended September 30, 2026. Ultragenyx announced the schedule on October 27 but did not include financial figures in its announcement.

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on developing and commercializing products for serious rare and ultra-rare genetic diseases. Its shares trade on Nasdaq under the ticker RARE.

Webcast and replay

A live webcast will be available through the events and presentations section of the company’s website. A replay will be available for three months.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.